The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.

Gupta, Diviya; Kato, Shumei; Kurzrock, Razelle

Gupta, Diviya; Kato, Shumei; Kurzrock, Razelle.

Gupta D; School of Medicine, University of California San Diego, La Jolla, CA, USA.
Kato S; Center for Personalized Cancer Therapy and Division of Hematology/Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology/Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.

J Immunother Precis Oncol ; 4(2): 56-63, 2021 May.

Article in English | MEDLINE | ID: covidwho-1264797

Keywords

COVID-19; NCI-designated comprehensive cancer center; cancer clinical trials; telemedicine; trial enrollment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: J Immunother Precis Oncol Year: 2021 Document Type: Article Affiliation country: JIPO-20-30

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google